SDR Messaging and Objection Handling
The central principle: Explain the potential benefit, identify what it depends on, and propose a useful next step.
Distinguish Issuer Outreach From Investor Solicitation
This chapter’s scripts are for approaching companies about services and financing evaluation. Issuer outreach means contacting a company to discuss its capital needs and potential service arrangements.
Investor solicitation means communicating with prospective investors to encourage interest in or purchases of securities.
The distinction depends on the substance of the communication. A message discussing a company’s financing options differs from one promoting a particular investment’s price, returns, or purchase opportunity.
Regulation A permits certain testing-the-waters communications-communications that gauge interest in a potential offering-but they have specific requirements, including required notices and filing obligations. These business-development scripts are not substitutes for approved offering materials. [R46] If a recipient asks how to invest, route the inquiry through the approved investor process.
| Build | the | Core | Message |
|---|---|---|---|
| An effective | message has | four parts: | |
| Business relevance: Why the discussion may | matter to this company; Potential benefit: | What the service could | |
| help evaluate or accomplish; Scope: What | needs to be reviewed; Next step: | A clear, proportionate request. |
| General | message |
|---|---|
| “We help companies evaluate capital-raising structures | and the technology and services needed to administer |
| tokenized securities. | Depending on the business objective, that may include debt, royalty-linked instruments, or |
| equity. | An initial discussion would establish whether the approach is relevant to your financing plans.” |
| Listed-company | message |
|---|---|
| “We help public-company teams evaluate whether | a tokenized securities structure could support a defined |
| financing objective. | The review considers the proposed issuer, investor rights, existing financing arrangements, |
| and listed-company | requirements.” |
| IP-focused | message |
|---|---|
| “If your company has intellectual property | or licensing revenue relevant to its financing plans, we can explore |
| whether those rights could support an | appropriately structured investment. The first step is understanding |
| ownership, revenue, existing restrictions, and the | use of proceeds.” |
| Use the version that matches the | prospect’s circumstances. |
Lead With the Business Objective
A CEO or CFO may care about the financing result before the technology. Start with: Funding a specific project; Comparing financing alternatives; Preserving particular ownership or control interests; Financing a subsidiary; Structuring participation in defined revenue; Improving securities administration.
Then explain how tokenization might support the chosen arrangement. Tokenization means representing a security or its associated rights through digital tokens, with ownership records maintained wholly or partly through blockchain systems.
Tokenization does not determine the security’s economic rights. Those depend on the legal structure and documents. SEC staff guidance distinguishes issuer-sponsored securities from third-party arrangements that can provide different rights and risks. [R02] Plain-English explanation: “We first evaluate the financing structure. Tokenization is the digital method that may support its ownership records, transfer controls, and administration.”
Adapt the Message to the Executive
| Audience | Likely | concern | Useful | opening |
|---|---|---|---|---|
| CEO Growth, strategy, | and execution “What | would additional capital | allow the | |
| business | to | accomplish?” | ||
| CFO | Financing | economics, | reporting, | and |
constraints “How are you comparing the cost and obligations of your financing alternatives?” General counsel Legal rights, disclosures, and approvals “Which structural or contractual issues would your team need resolved?” Treasurer Cash needs, repayment, and existing debt “How does the proposed financing fit your cash plan and current obligations?” Business-unit leader Project funding and operational milestones “What investment is needed to reach the next commercial milestone?” Investor relations Shareholder understanding and communications “How would you explain the transaction’s purpose and effects to shareholders?” These are starting points. Listen for the individual’s actual concerns rather than assuming that every executive in the same role has identical priorities.
Cold-Call Scripts
| Script | A: | General | financing | discussion |
|---|---|---|---|---|
| “Hello [Name], this | is [Your Name] | with [Company]. We | help companies evaluate | capital-raising structures and |
| tokenized securities administration. Are | you the right person | to ask about financing | plans, or would that | be your |
CFO?”
If the person is responsible: “Are you currently evaluating capital for a specific project or business objective?”
| Script | B: | Public-company | financing | alternatives |
|---|---|---|---|---|
| “Hello [Name], this is | [Your Name] with [Company]. | I’m calling to ask | whether your team is | evaluating |
| alternatives for an | upcoming capital raise. | Depending on the | objective, our team | can assess debt, |
| revenue-linked, or equity structures | and the services needed | to execute them. Is | that relevant to your | current |
plans?”
| Script | C: | Research-based | IP | discussion |
|---|---|---|---|---|
| “Hello [Name], this | is [Your Name] | with [Company]. Your | recent [filing or | announcement] describes [specific |
| publicly disclosed development]. I | wanted to ask whether | financing that initiative is | part of your current | planning.” |
| If | relevant: | |||
| “Would a short | discussion about the | financing objective and | existing arrangements be | useful?” |
Only reference research you actually performed. Do not imply that publicly disclosed IP has already been approved as collateral or independently valued.
Email and Voicemail Examples
| Initial | |
|---|---|
| Subject: | Financing options for [Company or initiative] |
| Hi | [First Name], |
| I saw your recent disclosure about | [specific development]. |
| We help company teams evaluate whether | debt, royalty-linked, or equity structures-and tokenized securities |
| administration-fit a defined financing | objective. |
Would a 15-minute discussion with the person leading your financing review be useful?
| [Name][Title | and | Company][Contact | Information] |
|---|---|---|---|
| Follow-up | after | discovery | |
| Subject: Next | discussion: [Company] | financing evaluation | |
| Hi | [First | Name], | |
| Thank you for | explaining your plans | to fund [objective]. | |
| My understanding is that you are | evaluating approximately [amount], with [timing or | constraint] as an important |
consideration. The next discussion would focus on [two or three unresolved questions]. We suggest including [relevant participants].
Please correct anything I have misunderstood, and let us know a suitable time. [Name]
Voicemail
“Hello [Name], this is [Your Name] with [Company]. I’m calling about a possible discussion of financing alternatives for [Company or publicly disclosed initiative]. You can reach me at [number]. Again, [Your Name], [number].” Keep outreach specific and easy to answer. Use your organization’s approved channels, templates, and follow-up procedures.
Handle Objections Through Clarification
An objection is a concern, question, or reason the prospect gives for not proceeding. A useful response follows four steps: Acknowledge: Show that you understand the concern; Clarify: Ask what specifically matters; Answer: Address that issue within your knowledge and authority; Advance: Agree on a relevant next step-or close the conversation.
Example: Prospect: “We don’t want dilution.”
SDR: “Preserving ownership is an important consideration. Are you primarily concerned about parent-company common shares, voting control, or participation in future upside?” After clarification: “That helps define the review. Debt or a revenue-linked arrangement may address some ownership concerns, but each creates different obligations. A specialist discussion could compare those tradeoffs.” Do not begin arguing before understanding the objection.
| “We | Already | Have | a | Bank | or | Investment | Banker” |
|---|---|---|---|---|---|---|---|
| Response: “That is | useful context. We | would need to | understand their role | and your existing | commitments. Are | ||
| they addressing | the full | financing need, | or are | you evaluating | additional alternatives?” |
An investment banker advises on or participates in transactions such as capital raising, acquisitions, and securities distribution.
Existing advisers may be valuable participants in the discussion. Their agreements may also contain exclusivity, consent, or fee provisions.
Useful next step
“If there is an unresolved financing objective, we can determine whether our services would complement the existing arrangement.” Do not imply that the platform automatically replaces the company’s bank or adviser.
| “We | Don’t | Want | Anything | to | Do | With | Crypto” |
|---|---|---|---|---|---|---|---|
| Response: “The starting | point is a | defined security, such | as a note | or shares. Tokenization | describes how that | ||
| security may | be digitally | represented and | administered. We | can explain | the investor | rights and | operating |
| arrangements | before | discussing | the | technology | in | detail.” | |
| Then | clarify: | ||||||
| “Is your | concern mainly | about price | volatility, custody, | regulatory requirements, | or how | investors would | use the |
system?” The answer determines the next discussion.
A tokenized note still has credit risk. Tokenized shares still have business and market risk. Digital representation does not remove those risks or automatically add speculative cryptocurrency economics.
| “Will | This | Increase | Our | Market | Capitalization?” |
|---|---|---|---|---|---|
| Market capitalization is | generally the market | price of a | company’s common shares | multiplied by its | outstanding |
| common | shares. | ||||
| Response: “A financing | or commercialization strategy | may help investors | assess the business, | but tokenization | |
| does not automatically | increase the company’s | market capitalization. Any | effect depends on | the transaction’s | |
| economics, | execution, | and | the | market’s | response.” |
| If the | prospect refers | to IP | valuation: | ||
| “An asset valuation, | accounting recognition, and | the public share | price measure different | things. We should | |
| evaluate | each | separately.” | |||
| GAAP, or Generally | Accepted Accounting Principles, | is the accounting | framework used for | U.S. financial |
reporting. A tokenized transaction does not override GAAP recognition rules. An IP appraisal cannot simply be added to public-company market capitalization.
Useful next step
“We can discuss how the proposed transaction might affect financing, cash flows, disclosures, and ownership, with your accounting and legal advisers involved.”
| “We | Need | Non-Dilutive | Capital” |
|---|---|---|---|
| Response: “Which interests are you | trying to preserve: parent common-share | ownership, voting control, | |
| subsidiary ownership, | or future | economic participation?” | |
| Then explain | the relevant | tradeoff: |
Possible structure Ownership consideration Other obligation
Nonconvertible debt Generally avoids issuing equity under its terms Principal, interest, and possible collateral obligations Royalty-linked instrument May avoid issuing shares Participation in defined revenue or other payments Subsidiary equity May preserve parent share count Dilution of ownership in the subsidiary Preferred equity Creates an equity interest Negotiated preferences and possible conversion rights An instrument’s label does not establish its complete dilution effect. Conversion rights, warrants, and other terms require review.
| “Can | You | Guarantee | the | Raise | or | the | Timeline?” |
|---|---|---|---|---|---|---|---|
| Response: “The | funding commitment | depends on | the actual | agreements. The | timetable depends | on | |
| preparation, adviser | work, regulatory | review where | applicable, provider | readiness, and | investor demand. | We can | |
| establish | milestones | after | reviewing | the | transaction.” |
Ask:
“What business deadline is driving the timing?”
A milestone is a defined event used to track progress, such as completing financial statements or submitting offering documents.
If a company needs immediate cash, the team should evaluate whether the proposed offering route fits that need. Urgency does not remove preparation requirements.
Do not turn an estimated schedule into a commitment. “Will Investors Be Able to Sell Whenever They Want?” Response: “We need to distinguish whether a transfer is permitted from whether a buyer is available. Trading access, investor eligibility, restrictions, venue availability, and market demand all affect the ability to sell.” Liquidity means the practical ability to sell within a reasonable time at an acceptable price.
A transferable security can still be difficult to sell. Follow-up question: “Is your priority providing a possible secondary trading venue, or establishing a specific exit or redemption mechanism?” A redemption is a repurchase or repayment under the security’s terms. It is different from an investor selling to another investor.
Any redemption obligation must be established in the documents and evaluated for affordability. “Why Not Use an S-1, S-3, or Another Financing Route?” Response: “That is an important comparison. Regulation A is one possible route. Your counsel and financing team should compare eligibility, timing, costs, distribution, and ongoing obligations against the alternatives.” Form S-1 and Form S-3 are SEC registration forms used for securities offerings; S-3 has specific eligibility and transaction requirements.
An SDR should not claim Regulation A is always faster, cheaper, or more suitable.
Useful next step
“We can arrange a discussion focused on your financing objective and the alternatives already under consideration.” For a listed company, the right answer may be a registered offering, private financing, conventional debt, or another arrangement.
| “How | Much | Does | It | Cost?” |
|---|---|---|---|---|
| Response: “The cost | depends on the | structure, preparation needed, | provider engagements, and | ongoing |
| services. We | should identify | the scope | before presenting | an estimate.” |
| Separate | costs | into | meaningful | categories: |
| Legal work; Accounting | and audit work; | Brokerage or distribution | services; Technology setup | and operation; |
| Recordkeeping and transfer-agent | services; Custody and | funds administration; Approved | marketing; Ongoing | |
| reporting | and | investor | administration. |
Some charges may be fixed; others may depend on funds raised, transaction volume, or service usage. Useful question: “Are you comparing the initial preparation cost, the total offering cost, or the ongoing annual cost?” Use approved pricing and identify assumptions. Do not improvise a fee quote.
“We Have No Revenue” or “The IP Is Already Pledged”
No established revenue
“That changes the evaluation. A revenue-linked instrument needs a clearly defined payment source, and debt requires an assessment of repayment capacity. Other structures may be worth reviewing, but we should not assume that tokenization resolves the financing challenge.” Ask: “What evidence supports the commercialization plan, and what milestones would the funding achieve?”
| Existing | pledge |
|---|---|
| A pledge commits an asset as | security for an obligation. |
| “We would need to understand the | existing lender’s rights and the relevant agreements. Counsel can assess |
| whether additional financing, consent, or a | different structure is possible.” |
Do not suggest that moving an asset into a subsidiary automatically avoids existing creditor rights.
| “Send | Information” | or | “We’re | Not | Interested” |
|---|---|---|---|---|---|
| “Send | information” | ||||
| “Certainly. Which topic | would be most | useful: financing structures, | tokenization administration, or | the evaluation |
process?” Send the relevant approved material, then propose a proportionate next step: “After you review it, would a short discussion with your finance lead be useful?”
“Not interested”
“Understood. Thank you for your time.”
If the prospect remains open to discussion, one brief clarification may help: “Is that because you have no current financing need, or because the approach does not fit your plans?” Accept the answer. Record a clear rejection or contact preference accurately and follow the applicable process.
Close With a Defined Next Step
A productive call ends with agreement about: The purpose of the next discussion; Who should attend; What information is needed; Who will coordinate; The intended timing.
Example closing: “Based on what you described, the next useful step is a discussion with your CFO and counsel about the proposed issuer, existing financing restrictions, and the capital requirement. Our transaction team can then determine what further evaluation would involve.”
Internal call note
“Management is exploring approximately $12 million for production expansion. Preserving parent common-share ownership is a priority. Existing lender rights remain unresolved. CFO and counsel participation requested for the next meeting. No structure selected.” That note gives the team a reliable starting point.
